Katrin Lorenz

Mainz, RP, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications

Functional outcomes and cRORA incidence and progression over a 10-year course of anti-VEGF therapy for neovascular AMD.

Functional outcomes and cRORA incidence and progression over a 10-year course of anti-VEGF therapy for neovascular AMD.

Journal: European journal of ophthalmology
Published: July 24, 2026

Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III INSIGHT randomized clinical trial.

Comparability of aflibercept biosimilar with reference aflibercept in diabetic macular edema: subgroup analysis of the pivotal Phase-III INSIGHT randomized clinical trial.

Journal: Expert opinion on biological therapy
Published: May 08, 2026

Reply.

Reply.

Journal: Ophthalmology. Retina
Published: May 05, 2026

TES-GPS and VIRON: clinical trials on electrical stimulation for glaucomatous optic neuropathy

TES-GPS and VIRON: clinical trials on electrical stimulation for glaucomatous optic neuropathy

Journal: Die Ophthalmologie
Published: March 29, 2026

What do patients want in clinical trials? : Perspectives from ophthalmology and patient advocacy groups

What do patients want in clinical trials? : Perspectives from ophthalmology and patient advocacy groups

Journal: Die Ophthalmologie
Published: February 26, 2026

Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol.

Transcorneal electrical stimulation for the treatment of visual field defects in patients with open-angle glaucoma: a monocentric, randomised, double-masked, sham-controlled pilot study: the TES-GPS study protocol.

Journal: BMJ open
Published: February 09, 2026

Title Not Found

Title Not Found

Journal: Die Ophthalmologie
Published: January 07, 2026

Systemic Inflammation in Retinal Vein Occlusion and Its Role in Clinical Outcomes of Secondary Macular Edema.

Systemic Inflammation in Retinal Vein Occlusion and Its Role in Clinical Outcomes of Secondary Macular Edema.

Journal: Journal of clinical medicine
Published: November 26, 2025

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine®) with Latanoprost Eye Drops (Xalatan®) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.

Comparison of Circadian Efficacy of Tafluprost Eye Drops (Taflotan Sine®) with Latanoprost Eye Drops (Xalatan®) in the Treatment of Open-Angle Glaucoma and Ocular Hypertension.

Journal: Journal of clinical medicine
Published: November 11, 2025

CRIMSON : A multicentre randomised, sham-controlled, double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy

CRIMSON : A multicentre randomised, sham-controlled, double-masked, 72-week trial to study the safety, tolerability, pharmacokinetics, and efficacy of 3 dosing regimens of intravitreal BI 764524 in patients with moderate to severe non-proliferative diabetic retinopathy

Journal: Die Ophthalmologie
Published: October 21, 2025

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

Secukinumab in Moderate-to-Severe Graves Orbitopathy: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.

Journal: The Journal of clinical endocrinology and metabolism
Published: October 09, 2025

Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: 24-Month Results from the ANDROMEDA Study.

Adherence to Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: 24-Month Results from the ANDROMEDA Study.

Journal: Ophthalmology. Retina
Published: August 05, 2025
Showing 1-12 of 115

Last Updated: 09/26/2026